Frontera Therapeutics

Frontera Therapeutics

Cambridge, United States· Est. 2019

Frontera is a clinical-stage gene therapy company pioneering innovative therapies, with an international footprint and dedicated to delivering safe, effective and affordable gene therapy treatments to patients worldwide.Our efforts focus on addressing unmet medical needs in both large-market and rare diseases in ophthalmology, cardiology and neurology. Several of our programs have entered or completed Phase II clinical trials and demonstrated global "Best-in-Class" potential with strong compe...

Private Company

Total funding raised: $286.5M

About

Frontera is a clinical-stage gene therapy company pioneering innovative therapies, with an international footprint and dedicated to delivering safe, effective and affordable gene therapy treatments to patients worldwide.Our efforts focus on addressing unmet medical needs in both large-market and rare diseases in ophthalmology, cardiology and neurology. Several of our programs have entered or completed Phase II clinical trials and demonstrated global "Best-in-Class" potential with strong compe...

RNA & Gene Therapy

Funding History

4
Total raised:$286.5M
Grant$375KSep 21, 2024
Grant$1.1MSep 22, 2023
Series B$160MAug 15, 2022
Series A$125MMay 15, 2021